Valuation under the microscope

cross-section-of-pine-needle-under-microscope

Hedge fund valuation has emerged as a key concern among investors and regulators worldwide. The issue reached a tipping point during the financial crisis. As markets went into meltdown many hedge funds found they were unable to liquidate their holdings at the prices communicated to investors, forcing them to recalculate their net asset values (NAVs) or suspend or gate redemptions until markets recovered.

The adoption of robust valuation policies and procedures will go a long way towards restoring

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here